FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume

Journal of Surgical Oncology

Volumn 77, Issue 4, 2001, Pages 237-242

  Wagner, Jeffrey D ^a   Schauwecker, Donald S ^a   Davidson, Darrell ^a   Wenck, Stacie ^a   Jung, Sin Ho ^b   Hutchins, Gary ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cancer Pavilion   (United States)

Author keywords

Fluorodeoxyglucose; Lymph nodes; Melanoma; Metastases; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CALCULATION; CLINICAL ARTICLE; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEASUREMENT; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

FLUORODEOXYGLUCOSE F18; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034885050     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.1102     Document Type: Article

References (16)

1. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma
2. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose
3. Initial assessment of positron emission tomography for detection of subclinical regional lymphatic metastases in melanoma
4. Malignant melanoma: Staging with whole body positron emission tomography and 2-(F-18)-fluoro-2-deoxy-D-glucose
5. Primary staging and follow-up of high risk melanoma patients with whole body 18 F-fluorodeoxyglucose positron emission tomography. Results of a prospective study of 100 patients
6. The importance of whole body PET scans on the management of metastatic malignant melanoma
7. Positron emission tomography in the detection and management of metastatic melanoma
8. Prospective evaluation of 2-(18F)-2-deoxyglucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma
9. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy
10. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma
11. Which kinds of lymph node metastases can fdg-pet detect? A clinical study in melanoma
12. Positron emission tomography scanning in malignant melanoma. Clinical utility in patients with stage III disease
13. Accuracy of positron emission tomography in staging patients with malignant melanoma
14. Positron emission tomography and ultrasonography: A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma